Page last updated: 2024-10-31

n-(6-aminohexyl)-1-naphthalenesulfonamide and Cystadenocarcinoma

n-(6-aminohexyl)-1-naphthalenesulfonamide has been researched along with Cystadenocarcinoma in 3 studies

N-(6-aminohexyl)-1-naphthalenesulfonamide: calmodulin antagonist; RN given refers to parent cpd

Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kikuchi, Y3
Iwano, I2
Kato, K2
Miyauchi, M1
Sasa, H1
Nagata, I1
Kuki, E1
Oomori, K1
Kizawa, I1

Other Studies

3 other studies available for n-(6-aminohexyl)-1-naphthalenesulfonamide and Cystadenocarcinoma

ArticleYear
Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.
    Biochemical and biophysical research communications, 1984, Aug-30, Volume: 123, Issue:1

    Topics: Calmodulin; Cell Division; Cell Line; Cisplatin; Cystadenocarcinoma; Doxorubicin; Female; Humans; Ov

1984
Restorative effects of calmodulin antagonists on reduced cisplatin uptake by cisplatin-resistant human ovarian cancer cells.
    Gynecologic oncology, 1990, Volume: 39, Issue:2

    Topics: Biological Transport; Calmodulin; Cisplatin; Cystadenocarcinoma; Drug Resistance; Female; Humans; Ov

1990
Restorative effects of defective autologous lymphocyte cytotoxicity by calmodulin antagonists.
    Biochemical and biophysical research communications, 1985, Oct-30, Volume: 132, Issue:2

    Topics: Adenocarcinoma; Adult; Animals; Calmodulin; Cell Line; Cystadenocarcinoma; Cytotoxicity, Immunologic

1985